NBTX

Nanobiotix S.A.

Price

$43.24

return (12m)

380.44%

p/e

-17.90

p/bv

-18.08

DIVIDEND YIELD

0.00%

NBTX price

Nanobiotix

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NBTX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

12.20%

3 months

8.07%

1 year

380.44%

2 years

781.55%

5 years

229.83%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals NBTX

Valuation

P/E

-17.90

Sector -4.38

Industry -4.38

P/BV

-18.08

Sector 2.02

Industry 2.02

P/Revenue (PSR)

80.24

Sector -4.40

Industry -4.40

EV/EBITDA

-133.27

Sector -263.09

Industry -263.09

EV/EBIT

-125.85

Sector -702.90

Industry -702.90

P/EBITDA

-23.62

Sector -4.39

Industry -4.39

P/EBIT

-22.60

Sector -4.73

Industry -4.73

P/Total Assets

22.54

Sector 1.49

Industry 1.49

P/Net Current Assets

-17.07

Sector -11.70

Industry -11.70

P/Working Capital

291.28

Sector -3.19

Industry -3.19

EPS

-2.08

Sector -2.14

Industry -2.14

BVPS

-2.06

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-248.91%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-263.59%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.07

Sector 0.03

Industry 0.03

Profitability

ROE

101.02%

Sector -65.14%

Industry -65.14%

ROA

-125.96%

Sector -65.53%

Industry -65.53%

ROIC

-49.05%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

1.09

Sector 2.90

Industry 2.90

Net Debt / EBITDA

-3.10

Sector -6.07

Industry -6.07

Net Debt / EBIT

-2.93

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.43

Sector -1.07

Industry -1.07

Gross Debt / Equity

-1.05

Sector -0.05

Industry -0.05

Equity/Assets

-1.25

Sector 0.41

Industry 0.41

Liabilities/Assets

2.25

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

367.33%

Sector -

Industry -

5Y Earnings CAGR

12.53%

Sector -

Industry -

Fundamentals NBTX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
NBTX Nanobiotix S.A.	$43.24	380.44%	0.00%	-17.90	-18.08	101.02%	-100.00%
JNJ Johnson & Johnson	$271.64	57.43%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.08	20.74%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.33	32.79%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.31	-9.49%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$151.02	84.93%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$165.36	5.18%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.51	44.10%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.43	-49.79%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$836.36	42.29%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$434.98	52.52%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$106.49	52.17%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$846.67	25.72%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$544.90	39.45%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$230.89	56.92%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$38.49	5.74%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$218.15	57.10%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NBTX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Nanobiotix

Nanobiotix S.A.

Average Investor10 user rating

4.0 (3 people)

United States

23 years

Founded: 2003

2020

Time since IPO - 6 years

88

Employees

Nanobiotix S.A. (United States) is listed on the Nasdaq and has a market capitalization of $1.79 billion, with shareholders equity totaling $-98.93 million.

The company employs approximately 88 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nanobiotix S.A. reported $22.29 million in revenue, generating net income of $-99.94 million.

Key financial metrics include a P/E ratio of -17.90, a price-to-book (P/B) ratio of -18.08, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NBTX.

Market cap

$1.79 billion

Net worth

$-98.93 million

$-98,930,000.00

Assets

$79.34 million

$79,340,000.00

Total Shares Outstanding

48.00 million

48,000,000

Average Daily Trading Volume

$111.09 Thousand

$111,090.36

Sector

Health Care

Industry

Biotechnology

NBTX

NBTX revenue and profits

Financial Results NBTX

DRAG THE FRAME TO SEE MORE DATA

NBTX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$846.67 21,06% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$230.89 52,88% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$271.64 56,52% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.33 30,91% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$151.02 85,52% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$165.36 5,26% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.08 20,45% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$846.67 21,06% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$230.89 52,88% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$271.64 56,52% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.33 30,91% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$151.02 85,52% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$165.36 5,26% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.08 20,45% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Nanobiotix (NBTX) today?

A cotação de Nanobiotix (NBTX) hoje está em US$ 43.24, com uma variação de 380.44% em relação ao último ano. A cotação de Nanobiotix (NBTX) iniciou o ano negociando na casa dos US$ 23.12 e hoje está em US$ 43.24. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Nanobiotix (NBTX) e dados de ações do Ibovespa e mercados internacionais.

Quando Nanobiotix (NBTX) paga dividendos?

Nanobiotix (NBTX) não distribuiu dividendos no último ano.

Is Nanobiotix (NBTX) a good investment?

Atualmente, Nanobiotix (NBTX) está cotada a US$ 43.24, com um P/L de -17.90, representando um desvio de -574% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 380.44 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 380.44%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Nanobiotix (NBTX) stock?

Investir em ações de Nanobiotix (NBTX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Nanobiotix (NBTX) yield today?

A rentabilidade de Nanobiotix (NBTX) foi de 12.20% no último mês, 380.44% no último ano e 229.83% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Nanobiotix (NBTX) hoje, o investimento total seria de US$ 4,324.00, com base na cotação atual de US$ 43.24.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 20,774.23
Em 5 anos: US$ 14,261.85
Em 10 anos: US$ 4,324.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

NBTX

Nanobiotix S.A.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment NBTX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING NBTX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Nanobiotix

Nanobiotix S.A.

United States

23 years

2020

88

PROFIT X PRICE NBTX

Financial Results NBTX

NBTX cash flow

Asset, Revenue and Profit Growth - NBTX

NBTX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions